Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice

Publication Date:
2018-02-03
Publisher:
American Society of Hematology (ASH)
Print ISSN:
0006-4971
Electronic ISSN:
1528-0020
Topics:
Biology
Medicine
Keywords:
Thrombosis and Hemostasis
Published by:
_version_ 1836398773038743553
autor Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
beschreibung Coagulopathy is common in patients with traumatic brain injury (TBI) and predicts poor clinical outcomes. We have shown that brain-derived extracellular microvesicles, including extracellular mitochondria, play a key role in the development of TBI-induced coagulopathy. Here, we further show in mouse models that the apoptotic cell-scavenging factor lactadherin, given at a single dose of 400 μg/kg 30 minutes before (preconditioning) or 30 minutes after cerebral fluid percussion injury, prevented coagulopathy as defined by clotting time, fibrinolysis, intravascular fibrin deposition, and microvascular bleeding of the lungs. Lactadherin also reduced cerebral edema, improved neurological function, and increased survival. It achieved these protective effects by enhancing the clearance of circulating microvesicles through phosphatidylserine-mediated phagocytosis. Together, these results identify the scavenging system for apoptotic cells as a potential therapeutic target to prevent TBI-induced coagulopathy and improve the outcome of TBI.
citation_standardnr 6152984
datenlieferant ipn_articles
feed_id 310
feed_publisher American Society of Hematology (ASH)
feed_publisher_url http://www.hematology.org/
insertion_date 2018-02-03
journaleissn 1528-0020
journalissn 0006-4971
publikationsjahr_anzeige 2018
publikationsjahr_facette 2018
publikationsjahr_intervall 7984:2015-2019
publikationsjahr_sort 2018
publisher American Society of Hematology (ASH)
quelle Blood
relation http://www.bloodjournal.org/cgi/content/short/131/5/563?rss=1
schlagwort Thrombosis and Hemostasis
search_space articles
shingle_author_1 Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
shingle_author_2 Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
shingle_author_3 Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
shingle_author_4 Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
shingle_catch_all_1 Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
Thrombosis and Hemostasis
Coagulopathy is common in patients with traumatic brain injury (TBI) and predicts poor clinical outcomes. We have shown that brain-derived extracellular microvesicles, including extracellular mitochondria, play a key role in the development of TBI-induced coagulopathy. Here, we further show in mouse models that the apoptotic cell-scavenging factor lactadherin, given at a single dose of 400 μg/kg 30 minutes before (preconditioning) or 30 minutes after cerebral fluid percussion injury, prevented coagulopathy as defined by clotting time, fibrinolysis, intravascular fibrin deposition, and microvascular bleeding of the lungs. Lactadherin also reduced cerebral edema, improved neurological function, and increased survival. It achieved these protective effects by enhancing the clearance of circulating microvesicles through phosphatidylserine-mediated phagocytosis. Together, these results identify the scavenging system for apoptotic cells as a potential therapeutic target to prevent TBI-induced coagulopathy and improve the outcome of TBI.
Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
American Society of Hematology (ASH)
0006-4971
00064971
1528-0020
15280020
shingle_catch_all_2 Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
Thrombosis and Hemostasis
Coagulopathy is common in patients with traumatic brain injury (TBI) and predicts poor clinical outcomes. We have shown that brain-derived extracellular microvesicles, including extracellular mitochondria, play a key role in the development of TBI-induced coagulopathy. Here, we further show in mouse models that the apoptotic cell-scavenging factor lactadherin, given at a single dose of 400 μg/kg 30 minutes before (preconditioning) or 30 minutes after cerebral fluid percussion injury, prevented coagulopathy as defined by clotting time, fibrinolysis, intravascular fibrin deposition, and microvascular bleeding of the lungs. Lactadherin also reduced cerebral edema, improved neurological function, and increased survival. It achieved these protective effects by enhancing the clearance of circulating microvesicles through phosphatidylserine-mediated phagocytosis. Together, these results identify the scavenging system for apoptotic cells as a potential therapeutic target to prevent TBI-induced coagulopathy and improve the outcome of TBI.
Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
American Society of Hematology (ASH)
0006-4971
00064971
1528-0020
15280020
shingle_catch_all_3 Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
Thrombosis and Hemostasis
Coagulopathy is common in patients with traumatic brain injury (TBI) and predicts poor clinical outcomes. We have shown that brain-derived extracellular microvesicles, including extracellular mitochondria, play a key role in the development of TBI-induced coagulopathy. Here, we further show in mouse models that the apoptotic cell-scavenging factor lactadherin, given at a single dose of 400 μg/kg 30 minutes before (preconditioning) or 30 minutes after cerebral fluid percussion injury, prevented coagulopathy as defined by clotting time, fibrinolysis, intravascular fibrin deposition, and microvascular bleeding of the lungs. Lactadherin also reduced cerebral edema, improved neurological function, and increased survival. It achieved these protective effects by enhancing the clearance of circulating microvesicles through phosphatidylserine-mediated phagocytosis. Together, these results identify the scavenging system for apoptotic cells as a potential therapeutic target to prevent TBI-induced coagulopathy and improve the outcome of TBI.
Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
American Society of Hematology (ASH)
0006-4971
00064971
1528-0020
15280020
shingle_catch_all_4 Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
Thrombosis and Hemostasis
Coagulopathy is common in patients with traumatic brain injury (TBI) and predicts poor clinical outcomes. We have shown that brain-derived extracellular microvesicles, including extracellular mitochondria, play a key role in the development of TBI-induced coagulopathy. Here, we further show in mouse models that the apoptotic cell-scavenging factor lactadherin, given at a single dose of 400 μg/kg 30 minutes before (preconditioning) or 30 minutes after cerebral fluid percussion injury, prevented coagulopathy as defined by clotting time, fibrinolysis, intravascular fibrin deposition, and microvascular bleeding of the lungs. Lactadherin also reduced cerebral edema, improved neurological function, and increased survival. It achieved these protective effects by enhancing the clearance of circulating microvesicles through phosphatidylserine-mediated phagocytosis. Together, these results identify the scavenging system for apoptotic cells as a potential therapeutic target to prevent TBI-induced coagulopathy and improve the outcome of TBI.
Zhou, Y., Cai, W., Zhao, Z., Hilton, T., Wang, M., Yeon, J., Liu, W., Zhang, F., Shi, F.-D., Wu, X., Thiagarajan, P., Li, M., Zhang, J., Dong, J.-f.
American Society of Hematology (ASH)
0006-4971
00064971
1528-0020
15280020
shingle_title_1 Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
shingle_title_2 Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
shingle_title_3 Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
shingle_title_4 Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
timestamp 2025-06-30T23:32:24.352Z
titel Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
titel_suche Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice
topic W
WW-YZ
uid ipn_articles_6152984